Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Smart Surveillance Strategy for Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

NCT05282082 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05282082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Smart Surveillance Strategy for Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Completed
Start date
March 1, 2022
Completion date
June 30, 2024
Enrollment
2,105 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colonization, asymptomatic, nosocomial infection, pseudomonas aeruginosa